CryoPort, Inc. CYRX Biostorage Bioservices — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CryoPort, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: CryoPort, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CryoPort, Inc.'s biostorage bioservices — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CryoPort, Inc.'s biostorage bioservices — revenue?
- CryoPort, Inc. (CYRX) reported biostorage bioservices — revenue of $5.23M in Q1 2026.
- How has CryoPort, Inc.'s biostorage bioservices — revenue changed year-over-year?
- CryoPort, Inc.'s biostorage bioservices — revenue increased by 20.7% year-over-year, from $4.33M to $5.23M.
- What is the long-term trend for CryoPort, Inc.'s biostorage bioservices — revenue?
- Over 3 years (2022 to 2025), CryoPort, Inc.'s biostorage bioservices — revenue has grown at a 26.4% compound annual growth rate (CAGR), from $9.08M to $18.36M.
- What does biostorage bioservices — revenue mean?
- This metric represents the total revenue generated from specialized temperature-controlled storage and bioservices provided to the life sciences industry. It reflects the company's ability to monetize its infrastructure for preserving biological materials, such as biopharmaceuticals and reproductive samples, across its global facilities. Growth in this segment indicates increasing demand for outsourced cold-chain storage solutions and the successful expansion of the company's bioservices footprint.